IDEXX Laboratories acquires veterinary AI scribe platform CoVetAI
IDXX•IDEXX Laboratories agreed to acquire CoVetAI, an AI-powered clinical scribe and workflow platform for veterinary medicine. Financial terms were not disclosed, and Chicago Pacific Founders’ Pet Fund exited its investment in CoVetAI as part of the deal.
1. Acquisition details
IDEXX Laboratories agreed to acquire CoVetAI, an AI-powered clinical scribe and workflow platform for veterinary medicine. The deal expands IDEXX’s footprint in veterinary practice software; financial terms were not disclosed, and Chicago Pacific Founders’ Pet Fund exited its investment in CoVetAI.
